世界各国のリアルタイムなデータ・インテリジェンスで皆様をお手伝い
光音響イメージング市場規模、シェア、動向分析レポート：製品別（光音響トモグラフィ（PAT）、光音響顕微鏡（PAM））、タイプ別（前臨床、臨床）、用途別、地域別、セグメント別予測、2023年～2030年Photoacoustic Imaging Market Size, Share & Trends Analysis Report By Product (Photoacoustic Tomography (PAT), Photoacoustic Microscopy (PAM)), By Type (Pre-clinical, Clinical), By Application, By Region, And Segment Forecasts, 2023 - 2030 光音響イメージング市場の成長と動向 Grand View Research社の最新レポートによると、世界の光音響イメージング市場規模は2030年までに3億3902万米ドルに達すると予測されている。同市場は、2023年から2030年... もっと見る
本レポートは受注生産のため、ご納品のお時間をいただく場合がございます。 
サマリー光音響イメージング市場の成長と動向Grand View Research社の最新レポートによると、世界の光音響イメージング市場規模は2030年までに3億3902万米ドルに達すると予測されている。同市場は、2023年から2030年にかけてCAGR 19.27％で成長すると予測されている。慢性疾患の有病率の増加、研究開発活動におけるアプリケーションの拡大、ヘルスケア技術の急速な進歩が市場成長の主な要因である。 光音響イメージング（PAI）の進歩は、構造的情報と機能的情報のユニークな組み合わせを提供し、ヘルスケアにおける疾患の早期発見とモニタリングに価値をもたらしている。PAIは非侵襲的で、非電離放射線を使用するため、従来のイメージング手法よりも安全であり、患者や医療従事者にとって魅力的である。これらの要因が市場の成長を後押ししている。例えば、2023年8月、TomoWaveはLOIS-3D 3次元定量光音響トモグラフィ(qOAT)を発売した。光と音の最も魅力的な側面を利用したこの革新的な技術は、ヒト疾患の微小動物モデルの3次元可視化を、比類のない詳細さとコントラストで実現する。 予防医療に対する消費者の意識は高まっており、PAIは使いやすくなっている。近い将来、メーカー各社が光超音波イメージング・システムの販促活動を強化し、利用が加速することも予想される。また、低侵襲手術は成功確率が高い。そのため、診断や治療において、世界中の患者がより低侵襲なPAIを好んでおり、市場の拡大を後押ししている。 光音響イメージング市場レポートハイライト - 製品別では、光音響トモグラフィ（PAT）分野が、高解像度、マルチスケールイメージング、様々な疾患の正確な診断により、2022年に63.22%の最大収益シェアで市場を支配した。 - 用途別では、腫瘍分野が2022年に52.68%の最高収益シェアで市場を支配した。このシェアは、光音響イメージングが治療に対する腫瘍の反応をリアルタイムでモニタリングし、腫瘍医が化学療法などの治療効果を評価するのに役立っていることによる。 - タイプ別では、前臨床分野が2022年に79.57%の最大収益シェアで市場を支配し、これは研究開発の増加とイメージング技術の進歩による。 - 2022年の地域別市場全体では、北米が42.81%の最高売上高シェアで支配的であったが、これは同地域に多数の市場競合企業が存在することと、同地域で慢性疾患の有病率が高まっていることによる。 目次Table of ContentsChapter 1. Methodology and Scope 1.1. Market Segmentation & Scope 1.1.1. Technology 1.1.2. Type 1.1.3. Application 1.1.4. Regional scope 1.1.5. Estimates and forecast timeline 1.2. Research Methodology 1.3. Information Procurement 1.3.1. Purchased database 1.3.2. GVR’s internal database 1.3.3. Secondary sources 1.3.4. Primary research 1.3.5. Details of primary research 1.3.5.1. Data for Primary Interviews in North America 1.3.5.2. Data for primary interviews in Europe 1.3.5.3. Data for primary interviews in Asia Pacific 1.3.5.4. Data for Primary Interviews in Latin America 1.3.5.5. Data for Primary Interviews in MEA 1.4. Information or Data Analysis 1.4.1. Data analysis models 1.5. Market Formulation & Validation 1.6. Model Details 1.6.1. Commodity flow analysis (Model 1) 1.6.1.1. Approach 1: Commodity flow approach 1.6.2. Volume price analysis (Model 2) 1.6.2.1. Approach 2: Volume price analysis 1.7. List of Secondary Sources 1.8. List of Primary Sources 1.9. Objectives 1.9.1. Objective 1 1.9.2. Objective 2 Chapter 2. Executive Summary 2.1. Market Outlook 2.2. Segment Outlook 2.2.1. Product outlook 2.2.2. Type outlook 2.2.3. Application outlook 2.2.4. Regional outlook 2.3. Competitive Insights Chapter 3. Photoacoustic Imaging Market Variables, Trends & Scope 3.1. Market Lineage Outlook 3.1.1. Parent market outlook 3.1.2. Related/ancillary market outlook 3.2. Market Dynamics 3.2.1. Market Driver Analysis 3.2.1.1. Increasing prevalence of cancer 3.2.1.2. Rise in research studies in the field of non-ionizing radiation 3.2.1.3. Increasing range of applications 3.2.2. Market Restraint Analysis 3.2.2.1. Lack of skilled professionals 3.2.2.2. High cost of photoacoustic imaging system 3.2.2.3. Limited bandwidth to capture tomographic data 3.2.2.4. Limitations set by ANSI laser safety regulations 3.2.3. Market Opportunity Analysis 3.3. Photoacoustic Imaging Market Analysis Tools 3.3.1. Industry Analysis - Porter’s 3.3.1.1. Supplier power 3.3.1.2. Buyer power 3.3.1.3. Substitution threat 3.3.1.4. Threat of new entrant 3.3.1.5. Competitive rivalry 3.3.2. PESTEL Analysis 3.3.2.1. Political landscape 3.3.2.2. Technological landscape 3.3.2.3. Economic Landscape 3.3.3. Covid-19 Impact Analysis Chapter 4. Photoacoustic Imaging Market: Product Estimates & Trend Analysis 4.1. Definitions and Scope 4.1.1. Photoacoustic Tomography (PAT) 4.1.2. Photoacoustic Microscopy (PAM) 4.2. Product Market Share, 2018 & 2030 4.3. Segment Dashboard 4.4. Global Surgical Refractor Market by Product Outlook 4.5. Market Size & Forecasts and Trend Analyses, 2023 to 2030 for the following 4.5.1. Photoacoustic Tomography (PAT) 4.5.1.1. Photoacoustic tomography (PAT) Market Estimates and forecast 2018 to 2030 (USD Million) 4.5.2. Photoacoustic Microscopy (PAM) 4.5.2.1. Photoacoustic microscopy (PAM) market estimates and forecast 2018 to 2030 (USD Million) Chapter 5. Handheld Ultrasound Devices: Type Estimates & Trend Analysis 5.1. Definitions and Scope 5.1.1. Pre-Clinical 5.1.2. Clinical 5.2. Type Market Share, 2018 & 2030 5.3. Segment Dashboard 5.4. Global Photoacoustic Imaging Market by Type Outlook 5.5. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following 5.5.1. Pre-Clinical 5.5.1.1. Pre-Clinical market estimates and forecast 2018 to 2030 (USD Million) 5.5.2. Clinical 5.5.2.1. Clinical market estimates and forecast 2018 to 2030 (USD Million) Chapter 6. Photoacoustic Imaging Market: Application Estimates & Trend Analysis 6.1. Definitions and Scope 6.1.1. Oncology 6.1.2. Cardiology 6.1.3. Angiology 6.1.4. Histology 6.1.5. Interventional radiology 6.2. Application Market Share, 2018 & 2030 6.3. Segment Dashboard 6.4. Global Photoacoustic Imaging Market by Application Outlook 6.5. Market Size & Forecasts and Trend Analyses, 2023 to 2030 for the following 6.5.1. Oncology 6.5.1.1. Oncology market estimates and forecast 2018 to 2030 (USD Million) 6.5.2. Cardiology 6.5.2.1. Cardiology market estimates and forecast 2018 to 2030 (USD Million) 6.5.3. Angiology 6.5.3.1. Angiology market estimates and forecast 2018 to 2030 (USD Million) 6.5.4. Histology 6.5.4.1. Histology market estimates and forecast 2018 to 2030 (USD Million) 6.5.5. Interventional radiology 6.5.5.1. Interventional radiology market estimates and forecast 2018 to 2030 (USD Million) Chapter 7. Photoacoustic Imaging Market: Regional Estimates & Trend Analysis 7.1. Regional market share analysis, 2022 & 2030 7.2. Regional Market Dashboard 7.3. Global Regional Market Snapshot 7.4. Regional Market Share and Leading Players, 2022 7.4.1. North America 7.4.2. Europe 7.4.3. Asia Pacific 7.4.4. Latin America 7.4.5. Middle East and Africa 7.5. Market Application, & Forecasts and Trend Analysis, 2018 to 2030 7.6. North America 7.6.1. Market estimates and forecast, 2018 - 2030 (Revenue, USD Million) 7.6.2. U.S. 7.6.2.1. Key Country Dynamics 7.6.2.2. Competitive Scenario 7.6.2.3. Regulatory framework 7.6.2.4. Reimbursement scenario 7.6.2.5. U.S. market estimates and forecasts, 2018 - 2030 7.6.3. Canada 7.6.3.1. Key country dynamics 7.6.3.2. Competitive Scenario 7.6.3.3. Regulatory framework 7.6.3.4. Reimbursement scenario 7.6.3.5. Canada market estimates and forecasts, 2018 - 2030 7.7. Europe 7.7.1. UK 7.7.1.1. Key country dynamics 7.7.1.2. Competitive Scenario 7.7.1.3. Regulatory framework 7.7.1.4. Reimbursement scenario 7.7.1.5. UK market estimates and forecasts, 2018 - 2030 7.7.2. Germany 7.7.2.1. Key country dynamics 7.7.2.2. Competitive Scenario 7.7.2.3. Regulatory framework 7.7.2.4. Reimbursement scenario 7.7.2.5. Germany market estimates and forecasts, 2018 - 2030 7.7.3. France 7.7.3.1. Key country dynamics 7.7.3.2. Competitive Scenario 7.7.3.3. Regulatory framework 7.7.3.4. Reimbursement scenario 7.7.3.5. France market estimates and forecasts, 2018 - 2030 7.7.4. Italy 7.7.4.1. Key country dynamics 7.7.4.2. Competitive Scenario 7.7.4.3. Regulatory framework 7.7.4.4. Reimbursement scenario 7.7.4.5. Italy market estimates and forecasts, 2018 - 2030 7.7.5. Spain 7.7.5.1. Key country dynamics 7.7.5.2. Competitive Scenario 7.7.5.3. Regulatory framework 7.7.5.4. Reimbursement scenario 7.7.5.5. Spain market estimates and forecasts, 2018 - 2030 7.7.6. Denmark 7.7.6.1. Key country dynamics 7.7.6.2. Competitive Scenario 7.7.6.3. Regulatory framework 7.7.6.4. Reimbursement scenario 7.7.6.5. Denmark market estimates and forecasts, 2018 - 2030 7.7.7. Sweden 7.7.7.1. Key country dynamics 7.7.7.2. Competitive Scenario 7.7.7.3. Regulatory framework 7.7.7.4. Reimbursement scenario 7.7.7.5. Sweden market estimates and forecasts, 2018 - 2030 7.7.8. Norway 7.7.8.1. Key country dynamics 7.7.8.2. Competitive Scenario 7.7.8.3. Regulatory framework 7.7.8.4. Reimbursement scenario 7.7.8.5. Norway market estimates and forecasts, 2018 - 2030 7.8. Asia Pacific 7.8.1. Japan 7.8.1.1. Key country dynamics 7.8.1.2. Competitive Scenario 7.8.1.3. Regulatory framework 7.8.1.4. Reimbursement scenario 7.8.1.5. Japan market estimates and forecasts, 2018 - 2030 7.8.2. India 7.8.2.1. Key country dynamics 7.8.2.2. Competitive Scenario 7.8.2.3. Regulatory framework 7.8.2.4. Reimbursement scenario 7.8.2.5. India market estimates and forecasts, 2018 - 2030 7.8.3. China 7.8.3.1. Key country dynamics 7.8.3.2. Competitive Scenario 7.8.3.3. Regulatory framework 7.8.3.4. Reimbursement scenario 7.8.3.5. China market estimates and forecasts, 2018 - 2030 7.8.4. South Korea 7.8.4.1. Key country dynamics 7.8.4.2. Competitive Scenario 7.8.4.3. Regulatory framework 7.8.4.4. Reimbursement scenario 7.8.4.5. South Korea market estimates and forecasts, 2018 - 2030 7.8.5. Australia 7.8.5.1. Key country dynamics 7.8.5.2. Competitive Scenario 7.8.5.3. Regulatory framework 7.8.5.4. Reimbursement scenario 7.8.5.5. Australia market estimates and forecasts, 2018 - 2030 7.8.6. Thailand 7.8.6.1. Key country dynamics 7.8.6.2. Competitive Scenario 7.8.6.3. Regulatory framework 7.8.6.4. Reimbursement scenario 7.8.6.5. Thailand market estimates and forecasts, 2018 - 2030 7.9. Latin America 7.9.1. Brazil 7.9.1.1. Key country dynamics 7.9.1.2. Competitive Scenario 7.9.1.3. Regulatory framework 7.9.1.4. Reimbursement scenario 7.9.1.5. Brazil market estimates and forecasts, 2018 - 2030 7.9.2. Mexico 7.9.2.1. Key country dynamics 7.9.2.2. Competitive Scenario 7.9.2.3. Regulatory framework 7.9.2.4. Reimbursement scenario 7.9.2.5. Mexico market estimates and forecasts, 2018 - 2030 7.9.3. Argentina 7.9.3.1. Key country dynamics 7.9.3.2. Competitive Scenario 7.9.3.3. Regulatory framework 7.9.3.4. Reimbursement scenario 7.9.3.5. Argentina market estimates and forecasts, 2018 - 2030 7.10. MEA 7.10.1. SSouth Africa 7.10.1.1. Key country dynamics 7.10.1.2. Competitive Scenario 7.10.1.3. Regulatory framework 7.10.1.4. Reimbursement scenario 7.10.1.5. South Africa market estimates and forecasts, 2018 - 2030 7.10.2. SSaudi Arabia 7.10.2.1. Key country dynamics 7.10.2.2. Competitive Scenario 7.10.2.3. Regulatory framework 7.10.2.4. Reimbursement scenario 7.10.2.5. Saudi Arabia market estimates and forecasts, 2018 - 2030 7.10.3. UUAE 7.10.3.1. Key country dynamics 7.10.3.2. Competitive Scenario 7.10.3.3. Regulatory framework 7.10.3.4. Reimbursement scenario 7.10.3.5. UAE market estimates and forecasts, 2018 - 2030 7.10.4. KKuwait 7.10.4.1. Key country dynamics 7.10.4.2. Competitive Scenario 7.10.4.3. Regulatory framework 7.10.4.4. Reimbursement scenario 7.10.4.5. Kuwait market estimates and forecasts, 2018 - 2030 Chapter 8. Competitive Landscape 8.1. Recent Developments & Impact Analysis, By Key Market Participants 8.2. Company/Competition Categorization 8.2.1. Innovators 8.3. Vendor Landscape 8.3.1. List of key distributors and channel partners 8.3.2. Key customers 8.3.3. Key Company Market Share Analysis, 2022 8.3.4. Advantest Corporation 8.3.4.1. Company overview 8.3.4.2. Financial performance 8.3.4.3. Product benchmarking 8.3.4.4. Strategic initiatives 8.3.5. TomoWave 8.3.5.1. Company overview 8.3.5.2. Financial performance 8.3.5.3. Product benchmarking 8.3.5.4. Strategic initiatives 8.3.6. Kibero GmbH 8.3.6.1. Company overview 8.3.6.2. Financial performance 8.3.6.3. Product benchmarking 8.3.6.4. Strategic initiatives 8.3.7. FUJIFILM VisualSonics Inc. 8.3.7.1. Company overview 8.3.7.2. Financial performance 8.3.7.3. Product benchmarking 8.3.7.4. Strategic initiatives 8.3.8. Seno Medical Instruments 8.3.8.1. Company overview 8.3.8.2. Financial performance 8.3.8.3. Product benchmarking 8.3.8.4. Strategic initiatives 8.3.9. iThera Medical GmbH 8.3.9.1. Company overview 8.3.9.2. Financial performance 8.3.9.3. Product benchmarking 8.3.9.4. Strategic initiatives 8.3.10. Aspectus GmbH 8.3.10.1. Company overview 8.3.10.2. Financial performance 8.3.10.3. Product benchmarking 8.3.10.4. Strategic initiatives 8.3.11. Vibronix Inc. 8.3.11.1. Company overview 8.3.11.2. Financial performance 8.3.11.3. Product benchmarking 8.3.11.4. Strategic initiatives
SummaryPhotoacoustic Imaging Market Growth & Trends Table of ContentsTable of ContentsChapter 1. Methodology and Scope 1.1. Market Segmentation & Scope 1.1.1. Technology 1.1.2. Type 1.1.3. Application 1.1.4. Regional scope 1.1.5. Estimates and forecast timeline 1.2. Research Methodology 1.3. Information Procurement 1.3.1. Purchased database 1.3.2. GVR’s internal database 1.3.3. Secondary sources 1.3.4. Primary research 1.3.5. Details of primary research 1.3.5.1. Data for Primary Interviews in North America 1.3.5.2. Data for primary interviews in Europe 1.3.5.3. Data for primary interviews in Asia Pacific 1.3.5.4. Data for Primary Interviews in Latin America 1.3.5.5. Data for Primary Interviews in MEA 1.4. Information or Data Analysis 1.4.1. Data analysis models 1.5. Market Formulation & Validation 1.6. Model Details 1.6.1. Commodity flow analysis (Model 1) 1.6.1.1. Approach 1: Commodity flow approach 1.6.2. Volume price analysis (Model 2) 1.6.2.1. Approach 2: Volume price analysis 1.7. List of Secondary Sources 1.8. List of Primary Sources 1.9. Objectives 1.9.1. Objective 1 1.9.2. Objective 2 Chapter 2. Executive Summary 2.1. Market Outlook 2.2. Segment Outlook 2.2.1. Product outlook 2.2.2. Type outlook 2.2.3. Application outlook 2.2.4. Regional outlook 2.3. Competitive Insights Chapter 3. Photoacoustic Imaging Market Variables, Trends & Scope 3.1. Market Lineage Outlook 3.1.1. Parent market outlook 3.1.2. Related/ancillary market outlook 3.2. Market Dynamics 3.2.1. Market Driver Analysis 3.2.1.1. Increasing prevalence of cancer 3.2.1.2. Rise in research studies in the field of non-ionizing radiation 3.2.1.3. Increasing range of applications 3.2.2. Market Restraint Analysis 3.2.2.1. Lack of skilled professionals 3.2.2.2. High cost of photoacoustic imaging system 3.2.2.3. Limited bandwidth to capture tomographic data 3.2.2.4. Limitations set by ANSI laser safety regulations 3.2.3. Market Opportunity Analysis 3.3. Photoacoustic Imaging Market Analysis Tools 3.3.1. Industry Analysis - Porter’s 3.3.1.1. Supplier power 3.3.1.2. Buyer power 3.3.1.3. Substitution threat 3.3.1.4. Threat of new entrant 3.3.1.5. Competitive rivalry 3.3.2. PESTEL Analysis 3.3.2.1. Political landscape 3.3.2.2. Technological landscape 3.3.2.3. Economic Landscape 3.3.3. Covid-19 Impact Analysis Chapter 4. Photoacoustic Imaging Market: Product Estimates & Trend Analysis 4.1. Definitions and Scope 4.1.1. Photoacoustic Tomography (PAT) 4.1.2. Photoacoustic Microscopy (PAM) 4.2. Product Market Share, 2018 & 2030 4.3. Segment Dashboard 4.4. Global Surgical Refractor Market by Product Outlook 4.5. Market Size & Forecasts and Trend Analyses, 2023 to 2030 for the following 4.5.1. Photoacoustic Tomography (PAT) 4.5.1.1. Photoacoustic tomography (PAT) Market Estimates and forecast 2018 to 2030 (USD Million) 4.5.2. Photoacoustic Microscopy (PAM) 4.5.2.1. Photoacoustic microscopy (PAM) market estimates and forecast 2018 to 2030 (USD Million) Chapter 5. Handheld Ultrasound Devices: Type Estimates & Trend Analysis 5.1. Definitions and Scope 5.1.1. Pre-Clinical 5.1.2. Clinical 5.2. Type Market Share, 2018 & 2030 5.3. Segment Dashboard 5.4. Global Photoacoustic Imaging Market by Type Outlook 5.5. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following 5.5.1. Pre-Clinical 5.5.1.1. Pre-Clinical market estimates and forecast 2018 to 2030 (USD Million) 5.5.2. Clinical 5.5.2.1. Clinical market estimates and forecast 2018 to 2030 (USD Million) Chapter 6. Photoacoustic Imaging Market: Application Estimates & Trend Analysis 6.1. Definitions and Scope 6.1.1. Oncology 6.1.2. Cardiology 6.1.3. Angiology 6.1.4. Histology 6.1.5. Interventional radiology 6.2. Application Market Share, 2018 & 2030 6.3. Segment Dashboard 6.4. Global Photoacoustic Imaging Market by Application Outlook 6.5. Market Size & Forecasts and Trend Analyses, 2023 to 2030 for the following 6.5.1. Oncology 6.5.1.1. Oncology market estimates and forecast 2018 to 2030 (USD Million) 6.5.2. Cardiology 6.5.2.1. Cardiology market estimates and forecast 2018 to 2030 (USD Million) 6.5.3. Angiology 6.5.3.1. Angiology market estimates and forecast 2018 to 2030 (USD Million) 6.5.4. Histology 6.5.4.1. Histology market estimates and forecast 2018 to 2030 (USD Million) 6.5.5. Interventional radiology 6.5.5.1. Interventional radiology market estimates and forecast 2018 to 2030 (USD Million) Chapter 7. Photoacoustic Imaging Market: Regional Estimates & Trend Analysis 7.1. Regional market share analysis, 2022 & 2030 7.2. Regional Market Dashboard 7.3. Global Regional Market Snapshot 7.4. Regional Market Share and Leading Players, 2022 7.4.1. North America 7.4.2. Europe 7.4.3. Asia Pacific 7.4.4. Latin America 7.4.5. Middle East and Africa 7.5. Market Application, & Forecasts and Trend Analysis, 2018 to 2030 7.6. North America 7.6.1. Market estimates and forecast, 2018 - 2030 (Revenue, USD Million) 7.6.2. U.S. 7.6.2.1. Key Country Dynamics 7.6.2.2. Competitive Scenario 7.6.2.3. Regulatory framework 7.6.2.4. Reimbursement scenario 7.6.2.5. U.S. market estimates and forecasts, 2018 - 2030 7.6.3. Canada 7.6.3.1. Key country dynamics 7.6.3.2. Competitive Scenario 7.6.3.3. Regulatory framework 7.6.3.4. Reimbursement scenario 7.6.3.5. Canada market estimates and forecasts, 2018 - 2030 7.7. Europe 7.7.1. UK 7.7.1.1. Key country dynamics 7.7.1.2. Competitive Scenario 7.7.1.3. Regulatory framework 7.7.1.4. Reimbursement scenario 7.7.1.5. UK market estimates and forecasts, 2018 - 2030 7.7.2. Germany 7.7.2.1. Key country dynamics 7.7.2.2. Competitive Scenario 7.7.2.3. Regulatory framework 7.7.2.4. Reimbursement scenario 7.7.2.5. Germany market estimates and forecasts, 2018 - 2030 7.7.3. France 7.7.3.1. Key country dynamics 7.7.3.2. Competitive Scenario 7.7.3.3. Regulatory framework 7.7.3.4. Reimbursement scenario 7.7.3.5. France market estimates and forecasts, 2018 - 2030 7.7.4. Italy 7.7.4.1. Key country dynamics 7.7.4.2. Competitive Scenario 7.7.4.3. Regulatory framework 7.7.4.4. Reimbursement scenario 7.7.4.5. Italy market estimates and forecasts, 2018 - 2030 7.7.5. Spain 7.7.5.1. Key country dynamics 7.7.5.2. Competitive Scenario 7.7.5.3. Regulatory framework 7.7.5.4. Reimbursement scenario 7.7.5.5. Spain market estimates and forecasts, 2018 - 2030 7.7.6. Denmark 7.7.6.1. Key country dynamics 7.7.6.2. Competitive Scenario 7.7.6.3. Regulatory framework 7.7.6.4. Reimbursement scenario 7.7.6.5. Denmark market estimates and forecasts, 2018 - 2030 7.7.7. Sweden 7.7.7.1. Key country dynamics 7.7.7.2. Competitive Scenario 7.7.7.3. Regulatory framework 7.7.7.4. Reimbursement scenario 7.7.7.5. Sweden market estimates and forecasts, 2018 - 2030 7.7.8. Norway 7.7.8.1. Key country dynamics 7.7.8.2. Competitive Scenario 7.7.8.3. Regulatory framework 7.7.8.4. Reimbursement scenario 7.7.8.5. Norway market estimates and forecasts, 2018 - 2030 7.8. Asia Pacific 7.8.1. Japan 7.8.1.1. Key country dynamics 7.8.1.2. Competitive Scenario 7.8.1.3. Regulatory framework 7.8.1.4. Reimbursement scenario 7.8.1.5. Japan market estimates and forecasts, 2018 - 2030 7.8.2. India 7.8.2.1. Key country dynamics 7.8.2.2. Competitive Scenario 7.8.2.3. Regulatory framework 7.8.2.4. Reimbursement scenario 7.8.2.5. India market estimates and forecasts, 2018 - 2030 7.8.3. China 7.8.3.1. Key country dynamics 7.8.3.2. Competitive Scenario 7.8.3.3. Regulatory framework 7.8.3.4. Reimbursement scenario 7.8.3.5. China market estimates and forecasts, 2018 - 2030 7.8.4. South Korea 7.8.4.1. Key country dynamics 7.8.4.2. Competitive Scenario 7.8.4.3. Regulatory framework 7.8.4.4. Reimbursement scenario 7.8.4.5. South Korea market estimates and forecasts, 2018 - 2030 7.8.5. Australia 7.8.5.1. Key country dynamics 7.8.5.2. Competitive Scenario 7.8.5.3. Regulatory framework 7.8.5.4. Reimbursement scenario 7.8.5.5. Australia market estimates and forecasts, 2018 - 2030 7.8.6. Thailand 7.8.6.1. Key country dynamics 7.8.6.2. Competitive Scenario 7.8.6.3. Regulatory framework 7.8.6.4. Reimbursement scenario 7.8.6.5. Thailand market estimates and forecasts, 2018 - 2030 7.9. Latin America 7.9.1. Brazil 7.9.1.1. Key country dynamics 7.9.1.2. Competitive Scenario 7.9.1.3. Regulatory framework 7.9.1.4. Reimbursement scenario 7.9.1.5. Brazil market estimates and forecasts, 2018 - 2030 7.9.2. Mexico 7.9.2.1. Key country dynamics 7.9.2.2. Competitive Scenario 7.9.2.3. Regulatory framework 7.9.2.4. Reimbursement scenario 7.9.2.5. Mexico market estimates and forecasts, 2018 - 2030 7.9.3. Argentina 7.9.3.1. Key country dynamics 7.9.3.2. Competitive Scenario 7.9.3.3. Regulatory framework 7.9.3.4. Reimbursement scenario 7.9.3.5. Argentina market estimates and forecasts, 2018 - 2030 7.10. MEA 7.10.1. SSouth Africa 7.10.1.1. Key country dynamics 7.10.1.2. Competitive Scenario 7.10.1.3. Regulatory framework 7.10.1.4. Reimbursement scenario 7.10.1.5. South Africa market estimates and forecasts, 2018 - 2030 7.10.2. SSaudi Arabia 7.10.2.1. Key country dynamics 7.10.2.2. Competitive Scenario 7.10.2.3. Regulatory framework 7.10.2.4. Reimbursement scenario 7.10.2.5. Saudi Arabia market estimates and forecasts, 2018 - 2030 7.10.3. UUAE 7.10.3.1. Key country dynamics 7.10.3.2. Competitive Scenario 7.10.3.3. Regulatory framework 7.10.3.4. Reimbursement scenario 7.10.3.5. UAE market estimates and forecasts, 2018 - 2030 7.10.4. KKuwait 7.10.4.1. Key country dynamics 7.10.4.2. Competitive Scenario 7.10.4.3. Regulatory framework 7.10.4.4. Reimbursement scenario 7.10.4.5. Kuwait market estimates and forecasts, 2018 - 2030 Chapter 8. Competitive Landscape 8.1. Recent Developments & Impact Analysis, By Key Market Participants 8.2. Company/Competition Categorization 8.2.1. Innovators 8.3. Vendor Landscape 8.3.1. List of key distributors and channel partners 8.3.2. Key customers 8.3.3. Key Company Market Share Analysis, 2022 8.3.4. Advantest Corporation 8.3.4.1. Company overview 8.3.4.2. Financial performance 8.3.4.3. Product benchmarking 8.3.4.4. Strategic initiatives 8.3.5. TomoWave 8.3.5.1. Company overview 8.3.5.2. Financial performance 8.3.5.3. Product benchmarking 8.3.5.4. Strategic initiatives 8.3.6. Kibero GmbH 8.3.6.1. Company overview 8.3.6.2. Financial performance 8.3.6.3. Product benchmarking 8.3.6.4. Strategic initiatives 8.3.7. FUJIFILM VisualSonics Inc. 8.3.7.1. Company overview 8.3.7.2. Financial performance 8.3.7.3. Product benchmarking 8.3.7.4. Strategic initiatives 8.3.8. Seno Medical Instruments 8.3.8.1. Company overview 8.3.8.2. Financial performance 8.3.8.3. Product benchmarking 8.3.8.4. Strategic initiatives 8.3.9. iThera Medical GmbH 8.3.9.1. Company overview 8.3.9.2. Financial performance 8.3.9.3. Product benchmarking 8.3.9.4. Strategic initiatives 8.3.10. Aspectus GmbH 8.3.10.1. Company overview 8.3.10.2. Financial performance 8.3.10.3. Product benchmarking 8.3.10.4. Strategic initiatives 8.3.11. Vibronix Inc. 8.3.11.1. Company overview 8.3.11.2. Financial performance 8.3.11.3. Product benchmarking 8.3.11.4. Strategic initiatives
ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。本レポートと同分野（医療機器）の最新刊レポート
Grand View Research社の医用画像処理分野での最新刊レポート
本レポートと同じKEY WORD（tomography）の最新刊レポート
よくあるご質問Grand View Research社はどのような調査会社ですか?グランドビューリサーチ（Grand View Research）は通信技術、化学品、材料、ヘルスケア、エネルギーなど広範な市場を対象にした調査報告書を出版しています。 もっと見る 調査レポートの納品までの日数はどの程度ですか?在庫のあるものは速納となりますが、平均的には 3-４日と見て下さい。
注文の手続きはどのようになっていますか?1)お客様からの御問い合わせをいただきます。
お支払方法の方法はどのようになっていますか?納品と同時にデータリソース社よりお客様へ請求書（必要に応じて納品書も）を発送いたします。
データリソース社はどのような会社ですか?当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
|
